Carolyn Walsh

Carolyn Walsh is an accomplished executive in the healthcare and technology sectors, currently serving as Chief Commercial Officer at DermaSensor, Inc. since May 2025, where the focus is on transforming skin cancer detection. Prior to this role, Carolyn held the position of Chief Commercial Officer at BioIntelliSense, Inc. from July 2019 to May 2025, leading innovations in remote patient monitoring. Carolyn also served as Vice President and Head of Sales and Business Development at Fitbit from September 2017 to August 2019, contributing to the company's prominence in the consumer wearables market. Previous experience includes senior marketing and business development roles at Qualcomm, HealthyCircles, LifeScan, Inc. (a Johnson & Johnson Company), Hydrade Beverage Company, Inc., and Coca Cola Amatil. Carolyn earned an MBA from the Quinlan School of Business at Loyola University Chicago.